Baidu
map

Mol Immunol:在过敏性鼻炎患者中,组织缺氧能够打乱芳香烃受体信号和Th17响应

2018-08-04 AlexYang MedSci原创

组织缺氧是过敏性鼻炎(AR)的关键特性,然而,在AR中组织缺氧产生的影响还没有完全的认识。最近,有研究人员通过调查组织缺氧影响的信号通路对Th17分化的作用,探究了组织缺氧对Th17响应的影响。研究包括了23名AR患者和15名健康的对照。在常氧和缺氧条件下,研究人员测量了HIF-1α, AhR, CYP1A1和CYP1B1的表达情况以及Th17细胞在CD4+T细胞中的表现情况。研究发现,与健康对照

组织缺氧是过敏性鼻炎(AR)的关键特性,然而,在AR中组织缺氧产生的影响还没有完全的认识。最近,有研究人员通过调查组织缺氧影响的信号通路对Th17分化的作用,探究了组织缺氧对Th17响应的影响。

研究包括了23名AR患者和15名健康的对照。在常氧和缺氧条件下,研究人员测量了HIF-1α, AhR, CYP1A1和CYP1B1的表达情况以及Th17细胞在CD4+T细胞中的表现情况。研究发现,与健康对照相比,来源于AR患者的CD4+T细胞中的HIF-1α和AhR的表达量更高。在组织缺氧环境条件下,AR患者和健康对照的HIF-1α在CD4+T细胞中的表达均提高。同时,在组织缺氧条件下,无毒AhR配体对Th17响应的抑制作用和它对IL-10产生的积极响应在AR患者和健康对照细胞中均受到了抑制。这些影响均是由于HIF-1α能够与AhR竞争性的结合ARNT产生,上述竞争性结合能够限制AhR通路的活性。

最后,研究人员指出,他们的研究表明了组织缺氧能够通过HIF-1α活性来减少AhR活性,从而促进Th17响应。因此,组织缺氧可能密切参与了AR的致病过程。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1990482, encodeId=0c8019904825a, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sat Jun 22 15:37:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047007, encodeId=c34f204e00701, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sun Jan 13 22:37:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338711, encodeId=8446338e1179, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Wed Aug 15 08:18:56 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811178, encodeId=3eb718111e8fd, content=<a href='/topic/show?id=0531869609a' target=_blank style='color:#2F92EE;'>#芳香烃受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86960, encryptionId=0531869609a, topicName=芳香烃受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Tue Dec 11 22:37:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413559, encodeId=f9c5141355988, content=<a href='/topic/show?id=9cd21e364df' target=_blank style='color:#2F92EE;'>#Th17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17364, encryptionId=9cd21e364df, topicName=Th17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 02:37:00 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1990482, encodeId=0c8019904825a, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sat Jun 22 15:37:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047007, encodeId=c34f204e00701, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sun Jan 13 22:37:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338711, encodeId=8446338e1179, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Wed Aug 15 08:18:56 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811178, encodeId=3eb718111e8fd, content=<a href='/topic/show?id=0531869609a' target=_blank style='color:#2F92EE;'>#芳香烃受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86960, encryptionId=0531869609a, topicName=芳香烃受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Tue Dec 11 22:37:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413559, encodeId=f9c5141355988, content=<a href='/topic/show?id=9cd21e364df' target=_blank style='color:#2F92EE;'>#Th17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17364, encryptionId=9cd21e364df, topicName=Th17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 02:37:00 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1990482, encodeId=0c8019904825a, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sat Jun 22 15:37:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047007, encodeId=c34f204e00701, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sun Jan 13 22:37:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338711, encodeId=8446338e1179, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Wed Aug 15 08:18:56 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811178, encodeId=3eb718111e8fd, content=<a href='/topic/show?id=0531869609a' target=_blank style='color:#2F92EE;'>#芳香烃受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86960, encryptionId=0531869609a, topicName=芳香烃受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Tue Dec 11 22:37:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413559, encodeId=f9c5141355988, content=<a href='/topic/show?id=9cd21e364df' target=_blank style='color:#2F92EE;'>#Th17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17364, encryptionId=9cd21e364df, topicName=Th17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 02:37:00 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-15 Jackie Li

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1990482, encodeId=0c8019904825a, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sat Jun 22 15:37:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047007, encodeId=c34f204e00701, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sun Jan 13 22:37:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338711, encodeId=8446338e1179, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Wed Aug 15 08:18:56 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811178, encodeId=3eb718111e8fd, content=<a href='/topic/show?id=0531869609a' target=_blank style='color:#2F92EE;'>#芳香烃受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86960, encryptionId=0531869609a, topicName=芳香烃受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Tue Dec 11 22:37:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413559, encodeId=f9c5141355988, content=<a href='/topic/show?id=9cd21e364df' target=_blank style='color:#2F92EE;'>#Th17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17364, encryptionId=9cd21e364df, topicName=Th17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 02:37:00 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1990482, encodeId=0c8019904825a, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sat Jun 22 15:37:00 CST 2019, time=2019-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047007, encodeId=c34f204e00701, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sun Jan 13 22:37:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338711, encodeId=8446338e1179, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Wed Aug 15 08:18:56 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811178, encodeId=3eb718111e8fd, content=<a href='/topic/show?id=0531869609a' target=_blank style='color:#2F92EE;'>#芳香烃受体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86960, encryptionId=0531869609a, topicName=芳香烃受体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Tue Dec 11 22:37:00 CST 2018, time=2018-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413559, encodeId=f9c5141355988, content=<a href='/topic/show?id=9cd21e364df' target=_blank style='color:#2F92EE;'>#Th17#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17364, encryptionId=9cd21e364df, topicName=Th17)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 02:37:00 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-06 zhaojie88

相关资讯

Clin Transl Allergy:重度过敏性鼻炎能够影响睡眠和焦虑

过敏性鼻炎(AR)是一种高度流行的疾病,并且能够产生高的社会和医疗费用,并且对生活质量和睡眠质量也有明显的影响。过敏性鼻炎同样与一些心理障碍有关,比如焦虑或者抑郁。最近,有研究人员评估并比较了患有永久性AR患者与季节性AR患者在焦虑、抑郁、睡眠质量和生活改变方面情况。研究包括了670名西班牙成年人,他们患有永久性AR或者季节性AR,并根据他们的季节性症状分为永久性和季节性2个组。研究人员利用相关的

Asian Pac J Allergy Immunol:在中度到重度屋尘螨敏感过敏性鼻炎患者中,CD4+末端分化效应记忆T细胞减少

末端分化效应记忆(TEMRA)T细胞在激活后能够发挥有效的功能作用。在对屋尘螨(HDMs)过敏的过敏性鼻炎患者中,CD4+ T细胞亚型尤其是记忆细胞所占的比例还没有详细的研究。最近,有研究人员比较了CD4+ 记忆T细胞亚型的平均比例和绝对数量,主要在非过敏对照和AR患者、中度AR患者和中度到重度AR患者之间比较。研究包括了33名非过敏对照、28名中度AR和29名中度到重度AR患者,他们主要对粉尘螨

Med Sci Monit:辅助性T9细胞的激活与过敏性鼻炎关系研究

最近,有研究人员调查了辅助性T(TH)9细胞在过敏性鼻炎(AR)病理发展过程中的作用。研究人员在BALB/c小鼠中开发了一种AR模型,并且利用病毒编码的白介素(IL)-9沉默序列来减少IL-9的表达。研究包括了一个对照组、一个AR组、一个IL-9 shRNA+AR组和一个空载体+AR组,并且利用苏木精和伊红(H&E)染色来检测病理变化。研究人员还通过ELISA方法检测细胞因子的表达,利用流

Allergy Asthma Clin Immunol:青蒿素和翼管神经切除对卵清蛋白诱导的过敏性鼻炎的影响

通过打喷嚏、鼻痒、鼻漏鉴定的过敏性鼻炎(AR)影响着许多的人。最近,有研究人员探索了青蒿素单独使用或者结合翼管神经切除在卵清蛋白诱导的AR小鼠模型中的作用,并尝试阐释潜在的机制。研究人员对过敏性症状进行了评估来鉴定青蒿素单独使用或者组合翼管神经切除对AR的影响。研究人员通过ELISA测量了血清组胺、免疫球蛋白E(lgE)和炎症因子TNF, INF-γ, IL-1β IL-10, IL-4和IL-5

Nat Genet:全基因组关联和HLA精细定位研究鉴定过敏性鼻炎的风险位点和遗传途径

过敏性鼻炎过敏症状中最为常见的临床表现,在全世界范围内影响着4亿的人口,并且在西方国家中发生率正在增加。最近,有研究人员为了阐释过敏性鼻炎的遗传结构和理解潜在的疾病机制,在具有欧洲血统的59762个过敏性鼻炎案例和152358个对照中进行了元分析,并总共鉴定了41个过敏性鼻炎的风险位点,包括了20个之前与过敏性鼻炎不相关的位点,这些位点在一个重复的试验(60720个案例和618527个对照)中得到

盘点:过敏性鼻炎进展盘点

过敏性鼻炎主要由IgE介导的介质(主要是组胺)释放,并有多种免疫活性细胞和细胞因子等参与的鼻黏膜非感染性炎性疾病。其发生的必要条件有特异性抗原即引起机体免疫反应的物质、特应性个体、特异性抗原与特应型个体二者相遇。过敏性鼻炎是一个全球性健康问题,可导致许多疾病和劳动力丧失。梅斯医学小编整理了近期过敏性鼻炎的研究进展,与大家一起分享学习!【1】EBioMedicine:在过敏性鼻炎且伴随肥胖的患者

Baidu
map
Baidu
map
Baidu
map